Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Kyoung-Bun Lee

Clin Mol Hepatol. 2016;22(3):400-405. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0105

View: 11737 Download: 310 Web of Science: 13 Crossref: 12

Kyu Ho Lee, Mussin Nadiar Maratovich, Kyoung-Bun Lee

Clin Mol Hepatol. 2016;22(2):292-295. Published online June 25, 2016

DOI: https://doi.org/10.3350/cmh.2015.0102

View: 8362 Download: 147 Web of Science: 15 Crossref: 13

Kyoung-Bun Lee

Clin Mol Hepatol. 2014;20(3):313-316. Published online September 26, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.3.313

View: 6656 Download: 71 Web of Science: 11 Crossref: 14

1 |

Viewed By 5442	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5419	MAFLD: How is it different from NAFLD?
Viewed By 5299	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3965	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 3964	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 77	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search